PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,850,669 | +4.7% | 1,317,801 | +9.4% | 0.00% | 0.0% |
Q2 2023 | $21,833,513 | +182.9% | 1,204,940 | +315.4% | 0.00% | – |
Q1 2023 | $7,716,687 | -23.5% | 290,101 | -44.4% | 0.00% | – |
Q4 2022 | $10,083,494 | +126.0% | 521,650 | +144.2% | 0.00% | – |
Q3 2022 | $4,462,000 | +551.4% | 213,581 | +149.9% | 0.00% | – |
Q2 2022 | $685,000 | -78.1% | 85,468 | -80.9% | 0.00% | – |
Q1 2022 | $3,133,000 | -47.8% | 446,996 | +0.5% | 0.00% | – |
Q4 2021 | $6,002,000 | -14.9% | 444,629 | +6.4% | 0.00% | – |
Q3 2021 | $7,056,000 | -37.1% | 418,003 | +8.6% | 0.00% | -100.0% |
Q2 2021 | $11,211,000 | -25.0% | 385,008 | +1.3% | 0.00% | 0.0% |
Q1 2021 | $14,955,000 | +263.7% | 380,249 | +110.1% | 0.00% | – |
Q4 2020 | $4,112,000 | +51.0% | 180,991 | +50.6% | 0.00% | – |
Q3 2020 | $2,723,000 | – | 120,207 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |